205 related articles for article (PubMed ID: 18798267)
1. Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs.
Goldoni S; Iozzo RV
Int J Cancer; 2008 Dec; 123(11):2473-9. PubMed ID: 18798267
[TBL] [Abstract][Full Text] [Related]
2. Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans.
McEwan PA; Scott PG; Bishop PN; Bella J
J Struct Biol; 2006 Aug; 155(2):294-305. PubMed ID: 16884925
[TBL] [Abstract][Full Text] [Related]
3. A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity.
Goldoni S; Iozzo RA; Kay P; Campbell S; McQuillan A; Agnew C; Zhu JX; Keene DR; Reed CC; Iozzo RV
Oncogene; 2007 Jan; 26(3):368-81. PubMed ID: 16847455
[TBL] [Abstract][Full Text] [Related]
4. The low density lipoprotein receptor-related protein functions as an endocytic receptor for decorin.
Brandan E; Retamal C; Cabello-Verrugio C; Marzolo MP
J Biol Chem; 2006 Oct; 281(42):31562-71. PubMed ID: 16936287
[TBL] [Abstract][Full Text] [Related]
5. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation.
Seidler DG; Goldoni S; Agnew C; Cardi C; Thakur ML; Owens RT; McQuillan DJ; Iozzo RV
J Biol Chem; 2006 Sep; 281(36):26408-18. PubMed ID: 16835231
[TBL] [Abstract][Full Text] [Related]
6. The decorin sequence SYIRIADTNIT binds collagen type I.
Kalamajski S; Aspberg A; Oldberg A
J Biol Chem; 2007 Jun; 282(22):16062-7. PubMed ID: 17426031
[TBL] [Abstract][Full Text] [Related]
7. Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways.
Xie C; Mondal DK; Ulas M; Neill T; Iozzo RV
Am J Physiol Cell Physiol; 2022 Mar; 322(3):C554-C566. PubMed ID: 35171698
[TBL] [Abstract][Full Text] [Related]
8. Leucine-rich repeat region of decorin binds to filamin-A.
Yoshida K; Suzuki Y; Honda E; Amemiya K; Nakatani T; Ebina M; Narumi K; Satoh K; Munakata H
Biochimie; 2002 Apr; 84(4):303-8. PubMed ID: 12106908
[TBL] [Abstract][Full Text] [Related]
9. Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation.
Droguett R; Cabello-Verrugio C; Riquelme C; Brandan E
Matrix Biol; 2006 Aug; 25(6):332-41. PubMed ID: 16766169
[TBL] [Abstract][Full Text] [Related]
10. Decorin-mediated effects in cancer cell biology.
Zafiropoulos A; Tzanakakis GN
Connect Tissue Res; 2008; 49(3):244-8. PubMed ID: 18661352
[TBL] [Abstract][Full Text] [Related]
11. More than matrix: the multifaceted role of decorin in cancer.
Sofeu Feugaing DD; Götte M; Viola M
Eur J Cell Biol; 2013 Jan; 92(1):1-11. PubMed ID: 23058688
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the myostatin/Smad signaling pathway by short decorin-derived peptides.
El Shafey N; Guesnon M; Simon F; Deprez E; Cosette J; Stockholm D; Scherman D; Bigey P; Kichler A
Exp Cell Res; 2016 Feb; 341(2):187-95. PubMed ID: 26844629
[TBL] [Abstract][Full Text] [Related]
13. Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissue tumors.
Matsumine A; Shintani K; Kusuzaki K; Matsubara T; Satonaka H; Wakabayashi T; Iino T; Uchida A
J Surg Oncol; 2007 Oct; 96(5):411-8. PubMed ID: 17579351
[TBL] [Abstract][Full Text] [Related]
14. [The action of decorin in anti-fibrosis and anti-cancer].
Ma W; Tan Y; Cai S; Chen H; Du J; Cai S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):222-5. PubMed ID: 17333927
[TBL] [Abstract][Full Text] [Related]
15. Decorin binds myostatin and modulates its activity to muscle cells.
Miura T; Kishioka Y; Wakamatsu J; Hattori A; Hennebry A; Berry CJ; Sharma M; Kambadur R; Nishimura T
Biochem Biophys Res Commun; 2006 Feb; 340(2):675-80. PubMed ID: 16380093
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan.
Scott PG; McEwan PA; Dodd CM; Bergmann EM; Bishop PN; Bella J
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15633-8. PubMed ID: 15501918
[TBL] [Abstract][Full Text] [Related]
17. Receptor-mediated endocytosis of decorin: involvement of leucine-rich repeat structures.
Hausser H; Schönherr E; Müller M; Liszio C; Bin Z; Fisher LW; Kresse H
Arch Biochem Biophys; 1998 Jan; 349(2):363-70. PubMed ID: 9448726
[TBL] [Abstract][Full Text] [Related]
18. Interaction between myostatin and extracellular matrix components.
Miura T; Kishioka Y; Wakamatsu J; Hattori A; Nishimura T
Anim Sci J; 2010 Feb; 81(1):102-7. PubMed ID: 20163680
[TBL] [Abstract][Full Text] [Related]
19. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.
Gutierrez J; Osses N; Brandan E
J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756
[TBL] [Abstract][Full Text] [Related]
20. Endocytosis of the dermatan sulfate proteoglycan decorin utilizes multiple pathways and is modulated by epidermal growth factor receptor signaling.
Feugaing DD; Tammi R; Echtermeyer FG; Stenmark H; Kresse H; Smollich M; Schönherr E; Kiesel L; Götte M
Biochimie; 2007 May; 89(5):637-57. PubMed ID: 17335953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
